Neofect·CareLabs, New Beneficiaries in COVID-19 Response... Trump "Expanding Telemedicine Accessibility"

[Asia Economy Reporter Hyungsoo Park] As the novel coronavirus infection (COVID-19) spreads worldwide, interest in remote medical services is growing. Due to the shortage of hospital beds caused by the COVID-19 outbreak, patients who cannot be admitted to hospitals or who die while waiting for examination are increasing, leading governments around the world to temporarily allow remote medical services.

At 11:50 a.m. on the 18th, Neofect was trading at 3,675 won, up 29.86% from the previous day. Remote medical-related stocks such as CareLabs and Inseong Information are all showing strong performance.

As confirmed COVID-19 cases surged and more companies introduced telecommuting, remote work solution developers like RSUPPORT also soared. With the rapid rise of COVID-19-related diagnostic device companies and therapeutic developers, individual investors are also accelerating their search for new related stocks.

Neofect entered the U.S. market earlier this year. One of the response tasks to prevent the large-scale spread of COVID-19 in the U.S. is to expand accessibility to remote medical services.

On the 17th (local time), U.S. President Donald Trump attended a COVID-19 response task force press briefing at the White House and said, "We will expand access to remote medical services," adding, "Patients can receive medical consultations by phone or video without additional burden."

Neofect is expected to speed up overseas market expansion, including Europe, by considering the acquisition of specialized hospitals and clinics. According to related industries, Neofect recently received an official approval letter from the Massachusetts state government allowing insurance coverage for remote medical costs related to COVID-19.

Not only in the U.S., but also the Korean government, as the COVID-19 spread intensified, announced from the 24th of last month that "patients can receive medical consultations by phone without visiting hospitals or clinics, and proxy prescriptions by family members or guardians are allowed." It also enabled the transmission of prescriptions via fax and email, and the receipt of medicine through consultations between patients and pharmacists. This effectively allowed remote medical services.

Following the government's temporary allowance of remote medical services due to the COVID-19 impact at the end of last month, CareLabs officially launched the 'Goodoc Remote Medical Service' through its representative platform Goodoc. By using the Goodoc service, when both patients and medical institutions agree, prescriptions issuance and medical fee payments can be done online without visiting hospitals or pharmacies.

Globally, remote medical services are rapidly growing. According to Fortune Business Insights, the global telemedicine market size is expected to grow from $49.8 billion (approximately 62 trillion KRW) in 2018 to $266.8 billion (approximately 329 trillion KRW) by 2026.

This content was produced with the assistance of AI translation services.